JOUNCE THERAPEUTICS INC's ticker is JNCE and the CUSIP is 481116101. A total of 80 filers reported holding JOUNCE THERAPEUTICS INC in Q1 2019. The put-call ratio across all filers is - and the average weighting 0.7%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2021 | $273,000 | +145.9% | 40,853 | +282.9% | 0.00% | – |
| Q1 2021 | $111,000 | -89.8% | 10,669 | -92.9% | 0.00% | -100.0% |
| Q4 2020 | $1,086,000 | +7.6% | 150,731 | +38.2% | 0.00% | 0.0% |
| Q3 2020 | $1,009,000 | +34.0% | 109,061 | -7.6% | 0.00% | 0.0% |
| Q2 2020 | $753,000 | +50.9% | 118,074 | +5.5% | 0.00% | 0.0% |
| Q1 2020 | $499,000 | +2395.0% | 111,875 | +4901.1% | 0.00% | – |
| Q4 2019 | $20,000 | +300.0% | 2,237 | +56.1% | 0.00% | – |
| Q3 2019 | $5,000 | -44.4% | 1,433 | -24.5% | 0.00% | – |
| Q2 2019 | $9,000 | +125.0% | 1,898 | +222.2% | 0.00% | – |
| Q1 2019 | $4,000 | +300.0% | 589 | +181.8% | 0.00% | – |
| Q4 2018 | $1,000 | -50.0% | 209 | +2.0% | 0.00% | – |
| Q3 2018 | $2,000 | 0.0% | 205 | -1.4% | 0.00% | – |
| Q2 2018 | $2,000 | – | 208 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TRV GP II, LLC | 10,230,349 | $63,428,000 | 41.36% |
| TRV GP III, LLC | 3,048,780 | $18,902,000 | 9.26% |
| Omega Fund Management, LLC | 1,059,930 | $6,572,000 | 1.39% |
| Alambic Investment Management, L.P. | 50,622 | $314,000 | 0.13% |
| Spark Investment Management LLC | 244,300 | $1,514,000 | 0.07% |
| ALGERT GLOBAL LLC | 14,182 | $88,000 | 0.05% |
| Redmile Group, LLC | 254,590 | $1,578,000 | 0.05% |
| Granahan Investment Management | 125,533 | $778,000 | 0.04% |
| GSA CAPITAL PARTNERS LLP | 38,602 | $239,000 | 0.02% |
| Frontier Wealth Management LLC | 27,099 | $168,000 | 0.02% |